Live Research Database
Psoriasis
Hub: East Windsor, NJ
Connecting patients in East Windsor with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in New Jersey
Available Psoriasis Opportunities
6 RecruitingNCT06857942(Verify)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RECRUITING
Psoriasis
NCT04347473(Verify)
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
RECRUITING
Psoriasis
NCT03392337(Verify)
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
RECRUITING
Psoriasis
NCT03827876(Verify)
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in East Windsor through safe, transparent, and patient-first clinical trials."
Psoriasis Hubs in NJ
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT